RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Benitec Biopharma Stock

Benitec Biopharma ROE 2024

Benitec Biopharma ROE

-97.8

Ticker

BNTC

ISIN

US08205P1003

WKN

722783

In 2024, Benitec Biopharma's return on equity (ROE) was -97.8, a 1,446.75% increase from the -6.32 ROE in the previous year.

Benitec Biopharma Aktienanalyse

What does Benitec Biopharma do?

Benitec Biopharma Inc is a biopharmaceutical company based in the United States that focuses on developing groundbreaking therapies for the treatment of serious diseases. The company was founded in 1995 and is headquartered in Hayward, California. Benitec Biopharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Benitec Biopharma's Return on Equity (ROE)

Benitec Biopharma's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Benitec Biopharma's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Benitec Biopharma's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Benitec Biopharma’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Benitec Biopharma stock

What is the ROE (Return on Equity) of Benitec Biopharma this year?

The ROE of Benitec Biopharma this year is -97.8 undefined.

How has the Return on Equity (ROE) of Benitec Biopharma developed compared to the previous year?

The ROE of Benitec Biopharma has increased by 1,446.75% increased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Benitec Biopharma?

A high ROE indicates that Benitec Biopharma generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Benitec Biopharma?

A low ROE can indicate that Benitec Biopharma is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Benitec Biopharma affect the company?

A change in ROE (Return on Equity) of Benitec Biopharma can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Benitec Biopharma?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Benitec Biopharma?

Some factors that can influence Benitec Biopharma's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Benitec Biopharma pay?

Over the past 12 months, Benitec Biopharma paid a dividend of 0.04 USD . This corresponds to a dividend yield of about 0.47 %. For the coming 12 months, Benitec Biopharma is expected to pay a dividend of 0 USD.

What is the dividend yield of Benitec Biopharma?

The current dividend yield of Benitec Biopharma is 0.47 %.

When does Benitec Biopharma pay dividends?

Benitec Biopharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Benitec Biopharma?

Benitec Biopharma paid dividends every year for the past 0 years.

What is the dividend of Benitec Biopharma?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Benitec Biopharma located?

Benitec Biopharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von Benitec Biopharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Benitec Biopharma from 6/8/2018 amounting to 0.003 USD, you needed to have the stock in your portfolio before the ex-date on 6/1/2018.

When did Benitec Biopharma pay the last dividend?

The last dividend was paid out on 6/8/2018.

What was the dividend of Benitec Biopharma in the year 2023?

In the year 2023, Benitec Biopharma distributed 0 USD as dividends.

In which currency does Benitec Biopharma pay out the dividend?

The dividends of Benitec Biopharma are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Benitec Biopharma

Our stock analysis for Benitec Biopharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Benitec Biopharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.